Table of Contents
September 9, 2004
Volume 47, Issue 19
Pages 4633-4798
About the Cover: RRibbon rendered illustration of the nuclear receptor heterodimer RXRα(cyan):PPARRγ (red) ligand binding domains bound with coactivator peptides (magenta) and agonist ligands (space-filling atoms where green is carbon, red is oxygen, and blue is nitrogen) (Haffner, C. D.; et al. J. Med. Chem. 2004, 47, 2010-2029).
Miniperspective
Virulence Regulation and Quorum Sensing in Staphylococcal Infections: Competitive AgrC Antagonists as Quorum Sensing Inhibitors
Weng C. Chan, Barry J. Coyle, and Paul Williams
pp 4633–4641Publication Date (Web): July 16, 2004 (Perspective)
DOI: 10.1021/jm0400754
Letters
Potent and Orally Bioavailable Non-Peptide Antagonists at the Human Bradykinin B1 Receptor Based on a 2-Alkylamino-5-sulfamoylbenzamide Core
Timothy J. Ritchie, Edward K. Dziadulewicz, Andrew J. Culshaw, Werner Müller, Gillian M. Burgess, Graham C. Bloomfield, Gillian S. Drake, Andrew R. Dunstan, David Beattie, Glyn A. Hughes, Pam Ganju, Peter McIntyre, Stuart J. Bevan, Clare Davis, and Mohammed Yaqoob
pp 4642–4644Publication Date (Web): August 10, 2004 (Letter)
DOI: 10.1021/jm049747g
Discovery of Novel Heteroarylazoles That Are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic Activity
Jeffrey Roppe, Nicholas D. Smith, Dehua Huang, Lida Tehrani, Bowei Wang, Jeffrey Anderson, Jesse Brodkin, Janice Chung, Xiaohui Jiang, Christopher King, Benito Munoz, Mark A. Varney, Petpiboon Prasit, and Nicholas D. P. Cosford
pp 4645–4648Publication Date (Web): August 14, 2004 (Letter)
DOI: 10.1021/jm049828c
In Vitro Cytotoxic Activities of 2-Alkyl-4,6-diheteroalkyl-1,3,5-triazines: New Molecules in Anticancer Research
Rita Menicagli, Simona Samaritani, Giovanni Signore, Francesca Vaglini, and Lisa Dalla Via
pp 4649–4652Publication Date (Web): August 12, 2004 (Letter)
DOI: 10.1021/jm0495374
Articles
Fuzzy Pharmacophore Models from Molecular Alignments for Correlation-Vector-Based Virtual Screening
Steffen Renner and Gisbert Schneider
pp 4653–4664Publication Date (Web): August 11, 2004 (Article)
DOI: 10.1021/jm031139y
Structural Basis for the Potent Antisickling Effect of a Novel Class of Five-Membered Heterocyclic Aldehydic Compounds
Martin K. Safo, Osheiza Abdulmalik, Richmond Danso-Danquah, James C. Burnett, Samuel Nokuri, Gajanan S. Joshi, Faik N. Musayev, Toshio Asakura, and Donald J. Abraham
pp 4665–4676Publication Date (Web): August 06, 2004 (Article)
DOI: 10.1021/jm0498001
Indolebutylamines as Selective 5-HT1A Agonists
Timo Heinrich, Henning Böttcher, Gerd D. Bartoszyk, Hartmut E. Greiner, Christoph A. Seyfried, and Christoph van Amsterdam
pp 4677–4683Publication Date (Web): August 10, 2004 (Article)
DOI: 10.1021/jm040792y
Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors
Timo Heinrich, Henning Böttcher, Rolf Gericke, Gerd D. Bartoszyk, Soheila Anzali, Christoph A. Seyfried, Hartmut E. Greiner, and Christoph van Amsterdam
pp 4684–4692Publication Date (Web): August 10, 2004 (Article)
DOI: 10.1021/jm040793q
A Prodrug Approach toward the Development of Water Soluble Fluoroquinolones and Structure−Activity Relationships of Quinoline-3-carboxylic Acids
William R. Baker, Shaopei Cai, Martin Dimitroff, Liming Fang, Kay K. Huh, David R. Ryckman, Xiao Shang, Ribhi M. Shawar, and Joseph H. Therrien
pp 4693–4709Publication Date (Web): August 13, 2004 (Article)
DOI: 10.1021/jm0497895
Design and Synthesis of a Nitrogen Mustard Derivative Stabilized by Apo-neocarzinostatin
Michael D. Urbaniak, John P. Bingham, John A. Hartley, Derek N. Woolfson, and Stephen Caddick
pp 4710–4715Publication Date (Web): August 17, 2004 (Article)
DOI: 10.1021/jm040790d
N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy
Francis X. Tavares, Joyce A. Boucheron, Scott H. Dickerson, Robert J. Griffin, Frank Preugschat, Stephen A. Thomson, Tony Y. Wang, and Hui-Qiang Zhou
pp 4716–4730Publication Date (Web): August 13, 2004 (Article)
DOI: 10.1021/jm040063i
CORES: An Automated Method for Generating Three-Dimensional Models of Protein/Ligand Complexes
Brian J. Hare, W. Patrick Walters, Paul R. Caron, and Guy W. Bemis
pp 4731–4740Publication Date (Web): July 27, 2004 (Article)
DOI: 10.1021/jm0499054
Design, Synthesis, and Biological Evaluation of 1,2,3,7-Tetrahydro-6H-purin-6-one and 3,7-Dihydro-1H-purine-2,6-dione Derivatives as Corticotropin-Releasing Factor1 Receptor Antagonists
Richard A. Hartz, Kausik K. Nanda, Charles L. Ingalls, Vijay T. Ahuja, Thaddeus F. Molski, Ge Zhang, Harvey Wong, Yong Peng, Michelle Kelley, Nicholas J. Lodge, Robert Zaczek, Paul J. Gilligan, and George L. Trainor
pp 4741–4754Publication Date (Web): August 07, 2004 (Article)
DOI: 10.1021/jm049787k
Dipeptidomimetic Ketomethylene Isosteres as Pro-moieties for Drug Transport via the Human Intestinal Di-/Tripeptide Transporter hPEPT1: Design, Synthesis, Stability, and Biological Investigations
Jon Våbenø, Carsten Uhd Nielsen, Truls Ingebrigtsen, Tore Lejon, Bente Steffansen, and Kristina Luthman
pp 4755–4765Publication Date (Web): August 10, 2004 (Article)
DOI: 10.1021/jm040780c
2-Pyrazolyl-N6-Substituted Adenosine Derivatives as High Affinity and Selective Adenosine A3 Receptor Agonists
Elfatih Elzein, Venkata Palle, Yuzhi Wu, Tenning Maa, Dewan Zeng, and Jeff Zablocki
pp 4766–4773Publication Date (Web): August 07, 2004 (Article)
DOI: 10.1021/jm049682h
Synthesis and Biological Activity of Analogues of the Antimicrotubule Agent N,β,β-Trimethyl-l-phenylalanyl-N1-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N1,3-dimethyl-l-valinamide (HTI-286)
Arie Zask, Gary Birnberg, Katherine Cheung, Joshua Kaplan, Chuan Niu, Emily Norton, Ronald Suayan, Ayako Yamashita, Derek Cole, Zhilian Tang, Girija Krishnamurthy, Robert Williamson, Gulnaz Khafizova, Sylvia Musto, Richard Hernandez, Tami Annable, Xiaoran Yang, Carolyn Discafani, Carl Beyer, Lee M. Greenberger, Frank Loganzo, and Semiramis Ayral-Kaloustian
pp 4774–4786Publication Date (Web): August 03, 2004 (Article)
DOI: 10.1021/jm040056u
Design of 2,5-Dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and Structure−Activity Relationships of a Series of Potent and Orally Active Corticotropin-Releasing Factor Receptor Antagonists
Chen Chen,Chen Chen, Keith M. Wilcoxen, Charles Q. Huang, Yun-Feng Xie, James R. McCarthy, Thomas R. Webb, Yun-Fei Zhu, John Saunders, Xin-Jun Liu, Ta-Kung Chen, Haig Bozigian, and Dimitri E. Grigoriadis
pp 4787–4798Publication Date (Web): August 06, 2004 (Article)
DOI: 10.1021/jm040058e